Navigation Links
Dutch Medical Equipment Producer Nucletron Strengthens Leading Position in Cancer Radiation Therapy Market
Date:6/2/2009

VEENENDAAL, The Netherlands, June 2 /PRNewswire/ -- Nucletron BV, the innovative cancer radiation solutions company, today announced the creation of an exclusive partnership and plan to merge with sector peer Isodose Control BV for an undisclosed sum. The two companies, headquartered in Veenendaal and Ede, the Netherlands, are complementary and the combination will strengthen Nucletron's position as global leader in the market for high-precision radiation therapy equipment and software, or brachytherapy.

The merger plans were announced by the two companies CEOs on Monday June 1 in Toronto, Canada, at the American Brachytherapy Society's annual conference.

"By combining strengths we will become the undisputed global market leader in brachytherapy, which offers quality, safe and effective treatment options for the most frequently occurring kinds of cancer," said Jos Lamers, CEO of Nucletron.

Nucletron is the world's number one medical equipment provider in the brachytherapy market, with a strong focus on customer support; Isodose Control has grown in six years to become number three and has an impressive product innovation track record.

"Isodose Control has developed a range of innovative brachytherapy products and has a promising range in development. Together with Nucletron, we look forward to speeding up the market introductions of these innovations to healthcare institutions and their patients worldwide," said Eric van't Hooft, CEO of Isodose Control BV.

Van 't Hooft in fact founded Nucletron in 1975 and built it into a successful technology company, before merging it to Dutch stock exchange-listed Delft Instruments NV in 1994. Van 't Hooft left nine years later to found Isodose Control in 2003. Van't Hooft, who was awarded a knighthood and the title Commander in the order of the Dutch Lion for his services to science, will become a member of the Executive Manag
'/>"/>

SOURCE Nucletron B V
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Cell Therapeutics Amends Modified Dutch Auction Tender Offer for up to $89.2 million of Its Outstanding Convertible Notes
2. Cell Therapeutics to Exchange up to $89.2 million of Its Outstanding Convertible Notes in a Modified Dutch Auction Tender Offer
3. Agendias MammaPrint(R) Receives Prestigious Award From Dutch Innovation Platform
4. Boost for Malaria Vaccine Development by Combining Strengths of Dutch and American Researchers
5. A Large-Scale Research Project by a Dutch Consortium Addressing a Global Problem
6. The Foundation for Biomedical Research Wins Telly Award for Majestic
7. SPO Medical Expands Professional Product Offering
8. BioMS Medical to present at the 2009 Symposium for the Canadian Society for Pharmaceutical Sciences
9. China Sky One Medical, Inc. Obtains Production Approval for Two New Drugs
10. China Sky One Medical, Inc. Signs Agreement with Taiwan Golden Biotechnology Corp. on Development of New Anti-Cancer Drug
11. The Hamner Institutes Announce Partnership With China Medical City

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...generation of ultrasmall transistors and more powe...emiconducting nanowires are closer to reality afte...iversity and the University of California at Los A...eate nanowires with layers of different materials ...h is a critical requirement for making efficient t...
(Date:11/25/2009)...PRNewswire/ -- Biotech firm Replikins Ltd., which ... 1918 pandemic through the prediction, outbreak, a...sued its latest biochemical analysis of the virus.... ("Swine Flu") virus has dropped from its peak of ... in the spring of 2009 to resting non-epidemic lev...
(Date:11/25/2009)..., BOCA RATON, Fla., Nov. 25 For m...so for BodyLogicMD. The nation,s largest and fast...ing exclusively in medically supervised bioidenti...ns in its network since November 2008 - from 21...e physician-owned centers, including one in Puerto...
(Date:11/25/2009).... 25 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. ( S... announced today that it executed,a joint venture ...ne,Technology Co., Ltd. (Sinovac Dalian). The JV w...uman-use vaccines. Sinovac will contribute its exp...izing world-class vaccines; the,other party will b...
Breaking Biology Technology:Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3
... Genetics, Flurizan Will Earn a 23%,Patient Share ...om Decision Resource...e of the,world,s leading research and advisory fir...s, finds that a drug,s effect on delaying the prog...r,s disease is the attribute that,most influences ...
...ference, LOUISVILLE, Colo., Feb. 5 Replidyne, In...ost a conference call on,Tuesday, February 26, 200...d year-end earnings. Additionally, Replidyne will ...uary 2008., Earnings conference call information...and CEO, and other members of Replidyne,s senio...
...logical,Technologies, Inc. (NTI(R)) (Nasdaq: NTII...rter 2008 financial results, for the quarter ended...l host a conference call on,February 11, 2008., H... and Chief Executive,Officer, and Craig W. Carlson...details for the call are as follows:, Live Call:...
Other Biology Technology:Flurizan's Effect in Delaying Progression From Mild Cognitive Impairment to Alzheimer's Disease is Superior to That of Aricept 2Replidyne to Report 2007 Fourth Quarter and Year-End Earnings 2Replidyne to Report 2007 Fourth Quarter and Year-End Earnings 3
(Date:11/23/2009)... new study by the Wildlife Conservation Society sa... swamp in the Republic of Congopart of the "mother...st yearare becoming increasingly threatened by gro...recommends protection of the swamp forests adjacen...rve after recent surveys confirmed that high densi...
(Date:11/23/2009)...mington, CT Current research suggests that a comm...e. The related report by Nichols et al, "Unique L...w Class of TLR2 Ligands Capable of Enhancing Autoi...e American Journal of Pathology . , Multiple sc...tacks the brain and spinal cord, affects nearly 1 ...
(Date:11/23/2009)...MES, Iowa - The only swine vaccine available for t...erd infected with the virus. The vaccination marks...erd diagnosed with the pandemic flu., Iowa State...ence, developed the vaccine this summer and has be... Iowa, Kansas and Illinois for several weeks., T...
Breaking Biology News(10 mins):A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Factors from common human bacteria may trigger multiple sclerosis 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Red List overlooks island species 9349 1Red List overlooks island species 9349 2Red List overlooks island species 9349 3Grant supports LSUHSC research on how like cell receptor systems determine very different functions 9344 1Grant supports LSUHSC research on how like cell receptor systems determine very different functions 9344 2San Francisco Bay Area Affiliate of the Susan G Komen for the Cure Funds Over 241 2 Million This Year to Community Outreach Programs 52668 1San Francisco Bay Area Affiliate of the Susan G Komen for the Cure Funds Over 241 2 Million This Year to Community Outreach Programs 52668 2San Francisco Bay Area Affiliate of the Susan G Komen for the Cure Funds Over 241 2 Million This Year to Community Outreach Programs 52668 3San Francisco Bay Area Affiliate of the Susan G Komen for the Cure Funds Over 241 2 Million This Year to Community Outreach Programs 52668 4
...d to making biofuels more economically competitive... to negotiate. For cellulosic ethanol production,...racterization of the genetic blueprint of the fung...gy Joint Genome Institute (DOE JGI) and collaborat...boratory (FPL). The research, entailing the ident...
...e appear to be genetically predisposed to develop...o pin down the genes responsible. Now, a specific... chromosome by a consortium of researchers workin...iatry and behavioral sciences at the Stanford Uni...very good chance of leading to a discovery of a g...
...clear medicine technique and molecular imaging to ...f getting rid of unneeded or abnormal cells—may he...o are at risk of developing heart failure, say res... , "Our study indicates that it is feasible to non...t failure patients using annexin A5 imaging," expl...
Other Biology News:Super-fermenting fungus genome sequenced 2Stanford-led study closes in on genes that may predispose some people to severe depression 2Stanford-led study closes in on genes that may predispose some people to severe depression 3Heart failure: Intervention possibilities from imaging programmed cell loss 2
Propidium Iodide Staining Solution Solution from BD Biosciences Pharmingen
BD Falcon Easy Grip Cell Culture Dish from BD Biosciences - Discovery Labware
...olymerase is a premium quality recombinant form of...le enzyme is suitable for a wide range of PCR appl...cible performance, each preparation is extensively...vaTaq DNA Polymerase possesses an integral 5′...
... a direct antibiotic-based selection system for re...pends solely on colony survival, eliminating the n...xpensive process provides close to 100% accuracy i...eal platform for robot colony picking. This clonin...
Biology Products: